WNT5A and prostate adenocarcinoma: The results of the correlation analysis between the β-catenin, Fzd8, Wnt5a and cyclin D1, divided into benign prostatic hyperplasia and prostate adenocarcinoma, are presented in Table 4 and Table 5.